About the Company
Athira Pharma is a late clinical stage American biopharmaceutical company developing small molecules to restore neuronal health and stop the neurodegeneration brought on by diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021. The company was founded in 2011 and is headquartered in Seattle. Funding that supports the company is from both public and private investment groups including the Alzheimer's Drug Discovery Foundation, Dolby Family Ventures, the State of Washington's Life Sciences Discovery Fund, The W Fund, WRF Capital, and other private investors. Leen Kawas served as the company's first President and CEO, but resigned in October 2021, after an independent special committee found she "altered images in scientific papers she authored." On October 21, 2021, Mark Litton, Ph.D., M.B.A. became Chief Executive Officer.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ATHA News
One Athira Pharma Insider Raised Their Stake In The Previous Year
Viewing insider transactions for Athira Pharma, Inc.'s ( NASDAQ:ATHA ) over the last year, we see that insiders ...
ATHA Athira Pharma, Inc.
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its lead product candidate is ...
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Experienced clinical development leader with a strong track record of advancing therapeutics from early development to ...
Athira Pharma Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
BOTHELL, Wash., April 15, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal ...
Athira Pharma Appoints Javier San Martin As New Chief Medical Officer
Biopharmaceutical company Athira Pharma, Inc. (ATHA) announced Monday the appointment of Javier San Martin as Chief Medical Officer.
Athira Pharma Inc (ATHA)
BOTHELL, Wash. - Athira Pharma, Inc. (NASDAQ: ATHA), a biopharmaceutical company at the late clinical stage, has presented new data at the AD/PD™ 2024 International Conference on... Athira Pharma ...
Athira Pharma, Inc.: Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health ...
Loading the latest forecasts...